Please wait...
About This Project
We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.
Recent Lab Notes From This Project

Browse Other Projects on Experiment
Related Projects
Ebola video voice-over recording in 10 African local languages
Ebola virus is spreading rapidly in West Africa. We are sharing a 3D animation explaining the symptoms of...
MyHealthEd
Each child deserves quality comprehensive sexual health education. No child is the same, so why...
Improving the detection of expired medication in developing countries to improve maternal health
Oxytocin prevents maternal mortality by reducing bleeding after giving birth. It's limited in rural areas...